摘要:
The invention relates to novel substituted benzoylcyclohexanediones of formula (I) in which A1 represents a single bond or represents alkanediyl (alkylene) having 1 to 3 carbon atoms, A2 represents alkanediyl (alkylene) having 1 to 3 carbon atoms, and R1, R2, R3, R4 and R5 are each as defined in the disclosure, and to novel intermediates, to processes for their preparation and to their use as herbicides.
摘要:
Composition, article of manufacture for and method of treating malaria in a human having an infestation of Plasmodium protozoans are described. The method comprises administering a therapeutically-effective amount of a compound of formula (I) or (IV), i.e. sufficient quantity to reduce the population of Plasmodium. The composition of the invention is a compound of formula (I) or (IV) with a pharmaceutical excipient. The article of manufacture is the composition in combination with labeling for treating malaria. The substituents are detailed in the specification.
摘要:
A compound represented by the formula [I]: [I] (wherein X represents oxygen, sulfur, NR4, or CHR5; Y represents oxygen or sulfur; R1 represents C1-6 alkyl, etc.; R2 represents optionally substituted phenyl, etc.; and R3 represents optionally substituted C1-6 alkyl, a group represented by any of the following formulae, etc.) [II] or a pharmaceutically acceptable composite of the compound; a medicinal composition containing any of these as an active ingredient; and a use thereof, etc.
摘要翻译:由式[I]表示的化合物:[I](其中X表示氧,硫,NR 4或CHR 5; Y表示氧或硫; R 1表示C 1-6烷基等; R 2表示任选取代的苯基等) ; R 3表示任选取代的C 1-6烷基,由下式中的任何一个表示的基团等)[II]或化合物的药学上可接受的复合物; 含有这些作为有效成分的药物组合物; 及其用途等
摘要:
A new class of imidazolines as 4-position esters with very potent anti-inflammatory as well as antimicrobial activity is described. The synthesis of these imidazolines includes a multicomponent reaction applicable to a combinatorial synthetic approach. The combination of these two key characteristics provides an effective therapeutic drug in the treatment of septic shock as well as many other inflammatory (arthritis and asthma) and infectious disorders. The use of this novel class of non-steroidal agents as anti-inflammatory agents (for the treatment of asthma, etc.), antibacterial agents, and antiseptic agents is described. The compounds are also useful in the treatment of tumors (such as cancers). The imidazolines are potent inhibitors of the transcription factor NF-kB as well as potent activity against the Gram (+) bacterium. The compositions are also useful for treating autoimmune diseases and for inhibiting rejection of organ and tissue transplants.
摘要:
Compounds of general formula (1) ##STR1## are described wherein Y is a halogen atom or a group --OR.sup.1, wherein R.sup.1 is an optionally substituted alkyl group; X is --O--, --S--, or --N(R.sup.6), wherein R.sup.6 is a hydrogen atom or an optionally substituted alkyl group; R.sup.2 is an optionally substituted cycloalkyl or cycloalkenyl group; R.sup.3 and R.sup.4, which may be the same or different, is each a hydrogen atom or an optionally substituted alkyl, --CO.sub.2 R.sup.7 (wherein R.sup.7 is a hydrogen atom, am optionally substituted alkyl, aralkyl, aryl, aryloxyalkyl, alkanoyloxyalkyl or aroyloxyalkyl group), --CONR.sup.8 R.sup.9 (where R.sup.8 and R.sup.9, which may be the same or different, is as defined for R.sup.7), --CSNR.sup.8 R.sup.9, --CN or --CH.sub.2 CN group; Z is --(CH.sub.2).sub.n -- where n is zero or an integer 1, 2 or 3; R.sup.5 is an optionally substituted monocyclic or bicyclic aryl group optionally containing one oremore heteroatoms selected from oxygen, sulphur or nitrogen atoms; and the salts, solvates, hydrates, prodrugs and N-oxides thereof. Compounds according to the invention are potent and selective phosphodiesterase type IV inhibitors and are useful in the prophylaxis and treatment of diseases such as asthma where an unwanted inflammatory response or muscular spasm is present.
摘要:
A hydrazide compound represented by the following formula (I), and a silver halide photographic photonsensitive material comprising the hydrazide compound: A--(B).sub.b (I) wherein A represents a heterocyclic group, a condensed polycyclic aromatic group or a group formed by connecting at least two aromatic groups to each other, B represents a group represented by the following formula (I-B) or (II-B), and b represents an integer from 2 to 6; --L.sub.1 --Ar.sub.1 --NHNH--G.sub.1 --R.sub.1 (I-B) --L.sub.3 --Ar.sub.3 --L.sub.2 --Ar.sub.2 --NHNH --G.sub.2 --R.sub.2(II-B) wherein each of G.sub.1 and G.sub.2 represents a carbonyl group, an oxalyl group, a sulfonyl group or a phosphoryl group; each of R.sub.1 and R.sub.2 represents a hydrogen atom or a blocking group; each of Ar.sub.1, Ar.sub.2 and Ar.sub.3 represents an aromatic group or an aromatic heterocyclic group; and each of L.sub.1, L.sub.2 and L.sub.3 represents a linkage group.
摘要翻译:由下式(I)表示的酰肼化合物和包含酰肼化合物:A-(B)b(I)的卤化银照相光敏材料,其中A表示杂环基,稠合多环芳族基或由 将至少两个芳族基团相互连接,B表示由下式(IB)或(II-B)表示的基团,b表示2〜6的整数; -L1-Ar1-NHNH-G1-R1( IB)-L3-Ar3-L2-Ar2-NHNH -G2-R2(II-B)其中G1和G2各自表示羰基,草酰基,磺酰基或磷酰基; R 1和R 2各自表示氢原子或封端基; Ar 1,Ar 2和Ar 3各自表示芳香族基或芳香族杂环基, L1,L2和L3中的每一个表示连接组。
摘要:
A preparation process of acyl halide or sulfonyl halide which comprises reacting corresponding carboxylic acid or sulfonic acid with a haloiminium salt represented by the general formula (1): ##STR1## wherein R.sup.1 and R.sup.2 are same or different lower alkyl groups, X is a halogen atom, and n is an integer of 2 or 3.
摘要:
Compounds of general formula (1) ##STR1## are described wherein Y is a halogen atom or a group --OR.sup.1, wherein R.sup.1 is an optionally substituted alkyl group; X is --O--, --S--, or --N(R.sup.6), wherein R.sup.6 is a hydrogen atom or an optionally substituted alkyl group; R.sup.2 is an optionally substituted cycloalkyl or cycloalkenyl group; R.sup.3 and R.sup.4, which may be the same or different, is each a hydrogen atom or an optionally substituted alkyl, --CO.sub.2 R.sup.7 (wherein R.sup.7 is a hydrogen atom, am optionally substituted alkyl, aralkyl, aryl, aryloxyalkyl, alkanoyloxyalkyl or aroyloxyalkyl group), --CONR.sup.8 R.sup.9 (where R.sup.8 and R.sup.9, which may be the same or different, is as defined for R.sup.7), --CSNR.sup.8 R.sup.9, --CN or --CH.sub.2 CN group; Z is --(CH.sub.2).sub.n -- where n is zero or an integer 1, 2 or 3; R.sup.5 is an optionally substituted monocyclic or bicyclic aryl group optionally containing one or more heteroatoms selected from oxygen, sulphur or nitrogen atoms; and the salts, solvates, hydrates, prodrugs and N-oxides thereof. Compounds according to the invention are potent and selective phosphodiesterase type IV inhibitors and are useful in the prophylaxis and treatment of diseases such as asthma where an unwanted inflammatory response or muscular spasm is present.
摘要:
The present invention relates to novel benzocycloalkylazolethione compounds which are dopamine .beta.-hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.